BIOCHEMICAL BASIS OF DIFFERENCES IN CHEMOTHERAPEUTIC SUSCEPTIBILITY TO CYTOSINE-ARABINOSIDE (ARA-C) OF HUMAN T-CELL AND B-CELL LINES

被引:0
|
作者
TAKAHASHI, I [1 ]
OHNUMA, T [1 ]
ROBOZ, J [1 ]
ARKIN, H [1 ]
HOLLAND, JF [1 ]
机构
[1] MT SINAI SCH MED,NEW YORK,NY 10029
来源
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:299 / 299
页数:1
相关论文
共 50 条
  • [21] EFFECTS OF CYTOSINE-ARABINOSIDE (ARA-C) AND DAUNORUBICIN (DNR) ON SURVIVAL AND CELL-CYCLE PROGRESSION OF CHINESE-HAMSTER OVARY (CHO) CELLS
    FRIED, J
    PEREZ, AG
    DOBLIN, J
    CLARKSON, B
    CELL AND TISSUE KINETICS, 1979, 12 (06): : 679 - 679
  • [22] SYNERGISTIC EFFECTS OF CISPLATINUM (CP) AND CYTOSINE-ARABINOSIDE (ARA-C) ON OVARIAN-CARCINOMA CELL-LINES DEMONSTRATED BY DUAL-PARAMETER FLOW-CYTOMETRY (FCM)
    KINGSTON, R
    RAMOS, R
    SEVIN, B
    SAKS, M
    DONATO, D
    AVERETTE, H
    GYNECOLOGIC ONCOLOGY, 1987, 26 (03) : 415 - 415
  • [23] ESTABLISHMENT AND CHARACTERIZATION OF A PRE-B ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) CELL-LINE FROM A PATIENT CLINICALLY RESISTANT TO CYTOSINE-ARABINOSIDE (ARA-C) AND ANTHRACYCLINES
    KHERADPOUR, A
    GOKER, E
    ELISSEYEFF, Y
    BERTINO, JR
    BLOOD, 1994, 84 (10) : A45 - A45
  • [24] CARBOHYDRATE DIFFERENCES IN HUMAN HIGH MOLECULAR-WEIGHT ANTIGENS OF B-CELL AND T-CELL LINES
    MORISHIMA, Y
    OGATA, S
    COLLINS, NH
    DUPONT, B
    LLOYD, KO
    IMMUNOGENETICS, 1982, 15 (05) : 529 - 535
  • [25] DIFFERENTIAL INHIBITION OF MITOGEN INDUCED T-CELL PROLIFERATION BY 5-AZACYTIDINE AND CYTOSINE-ARABINOSIDE
    SCHAUENSTEIN, K
    ROSSI, K
    CSORDAS, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (01) : 548 - 553
  • [26] DIFFERENCES IN PURINE METABOLIZING ENZYME-ACTIVITIES IN HUMAN LEUKEMIA T-CELL, B-CELL, AND NULL CELL LINES
    TRITSCH, GL
    MINOWADA, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 60 (06) : 1301 - 1304
  • [27] COMBINATION OF CYTOSINE-ARABINOSIDE (ARA-C), CYCLOPHOSPHAMIDE AND PREDNISONE IN THE TREATMENT OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA IN ADVANCED STAGES AND PROGRESSIVE DISEASE
    DEROSSI, G
    MAURO, FR
    PIZZO, F
    COLUZZI, S
    LUCIANI, M
    MANDELLI, F
    LEUKEMIA & LYMPHOMA, 1991, 5 : 101 - 103
  • [28] AMINO-ACID METABOLISM OF HUMAN T-CELL AND B-CELL LINES
    OHNUMA, T
    MINOWADA, J
    MOORE, GE
    WALCZAK, I
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 160 - 160
  • [29] Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines
    Castegnaro, Silvia
    Visco, Carlo
    Chieregato, Katia
    Bernardi, Martina
    Albiero, Elena
    Zanon, Cristina
    Madeo, Domenico
    Rodeghiero, Francesco
    LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2262 - 2268
  • [30] FLOW-CYTOMETRY AND CELL-KINETICS DURING TREATMENT OF HUMAN ACUTE LEUKEMIAS - KINETIC MANIPULATIONS OF LEUKEMIC-CELLS BY CYTOSINE-ARABINOSIDE (ARA-C) IN CORRELATION TO THERAPEUTIC RESPONSE
    BUCHNER, T
    HIDDEMANN, W
    WORMANN, B
    GOHDE, W
    SCHUMANN, J
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION A-PATHOLOGY, 1981, : 499 - 503